Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-23
Closed -$1.07K 854
2017
Q4
$1K Sell
23
-128
-85% -$5.91K ﹤0.01% 843
2017
Q3
$8K Buy
151
+128
+557% +$6.49K ﹤0.01% 659
2017
Q2
$1K Hold
23
﹤0.01% 832
2017
Q1
$1K Sell
23
-207
-90% -$10.5K ﹤0.01% 821
2016
Q4
$11K Buy
+230
New +$11.4K 0.01% 568

Other funds holding GSK

YorkBridge Wealth Partners's GSK Position: Q1 2018 in Review

YorkBridge Wealth Partners sold out of GSK (GSK) in Q1 2018, closing a stake of 23 shares — an estimated $1.07K sold.

YorkBridge Wealth Partners first reported a position in GSK in Q4 2016 and held it in 5 quarters. The position peaked at $11K in Q4 2016. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

  • YorkBridge Wealth Partners reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
  • YorkBridge Wealth Partners sold 23 GSK shares in Q1 2018, an estimated $1.07K.
  • YorkBridge Wealth Partners first reported a position in GSK in Q4 2016 and held it in 5 quarters.
  • YorkBridge Wealth Partners's GSK position peaked at $11K in Q4 2016.
  • 778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on YorkBridge Wealth Partners's 13F filing for Q1 2018, filed 15 May 2018.